Invea Therapeutics, Inc — Form D
Invea Therapeutics, Inc of GUILFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-22. The offering totals $5.8M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-22
- Form: D
- Accession: 0001906425-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.8M
- Amount sold: $1.5M
- Remaining: $4.2M
- Investors: 4
- Date of first sale: 2022-04-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-443077
Issuer
- Name: Invea Therapeutics, Inc
- CIK: 0001906425
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2614 BOSTON POST ROAD, SUITE 33B, GUILFORD, CT, 06437
- Phone: (203) 643-8002
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Kerrie Brady | Director | Boston, MA |
| Demetrios Kydonieus | Director | Guilford, CT |
| Sandeep Laumas | Director | Greenwich, CT |
| Vimal Mehta | Director | Guilford, CT |
| Jonathan Zalevsky | Director | Norfolk, VA |
| Michael Aiello | Executive Officer | Georgetown, TX |
| Salvatore Alesci | Executive Officer | Guilford, CT |
| "Shunichiro ""Steve""" Okada | Executive Officer | Guilford, CT |
| Krishnan Nandabalan | Promoter | Guilford, CT |
| Demetrios J Kydonieus | Director | Guilford, CT |
| Aman Kant | Executive Officer | Guilford, CT |
| Salvatore J Alesci | Executive Officer | Guilford, CT |
| Michael J Aiello | Executive Officer | Guilford, CT |
| Jonathan J Zalevsky | Director | Guilford, CT |
| "Shunichiro ""Steve""" J Okada | Executive Officer | Guilford, CT |
| Stephen J Doberstein | Director | Guilford, CT |
| Kerrie J Brady | Director | Guilford, CT |
| Krishnan Nandabalan | Director | Guilford, CT |
| Krishnan Nandabalan | Executive Officer | Guilford, CT |
Other filings by this issuer (2)
More